Dan Karlin

Dan Karlin is an accomplished medical professional with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as Chief Medical Officer at MindMed since February 2021, Karlin is instrumental in developing innovative treatments for brain health disorders. Additionally, roles as Assistant Professor at Tufts University and Advisor for several health-focused companies, including NightWare and 4YouandMe, underscore a commitment to advancing mental health and recovery solutions. Previously, Karlin held leadership positions at Pfizer, contributing to regulatory strategy and digital medicine initiatives. An educational background includes an MD from the University of Colorado, an MA in Medical Informatics from Columbia, and a BA in Neuroscience and Behavior from Columbia.